Teiji Sawa Selected Research

Type III Secretion Systems

1/2020	Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens.
2/2016	Epidemiological analysis of serum anti-Pseudomonas aeruginosa PcrV titers in adults.
1/2016	IV Immunoglobulin for Acute Lung Injury and Bacteremia in Pseudomonas aeruginosa Pneumonia.
6/2010	Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV - implications for anti-PcrV immunotherapy.
3/2009	An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity.
11/2004	Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
4/2004	Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU.
7/2002	Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Teiji Sawa Research Topics

Disease

12	Acute Lung Injury 11/2021 - 06/2002
11	Pneumonia (Pneumonitis) 01/2022 - 02/2004
9	Infections 03/2022 - 06/2006
7	Pain (Aches) 01/2019 - 09/2016
6	Hypersensitivity (Allergy) 01/2019 - 01/2017
6	Sepsis (Septicemia) 10/2016 - 01/2002
5	Bacteremia 04/2016 - 01/2002
4	Inflammation (Inflammations) 01/2022 - 10/2017
3	Hyperalgesia 12/2021 - 01/2017
3	Bacterial Infections (Bacterial Infection) 11/2019 - 06/2006
3	Edema (Dropsy) 12/2018 - 01/2014
3	Lung Injury 02/2009 - 07/2002
2	COVID-19 07/2022 - 01/2022
2	Neoplasms (Cancer) 04/2022 - 01/2015
2	Bacterial Pneumonia 01/2022 - 11/2021
2	Pathologic Constriction (Stenosis) 01/2017 - 01/2016
1	Coronavirus Infections 07/2022
1	Morbid Obesity 04/2022
1	Pulmonary Edema 01/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2021
1	Pseudomonas Infections 03/2020
1	Strabismus (Squint) 08/2019
1	Hyperargininemia 08/2019
1	Exotropia (Exophoria) 08/2019
1	Hyperammonemia 08/2019
1	Hemophilia A (Haemophilia) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Aortic Dissection 12/2018
1	Stroke (Strokes) 12/2018
1	Congenital Heart Defects (Congenital Heart Defect) 01/2018
1	Hypoxia (Hypoxemia) 01/2018

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2003
8	Type III Secretion SystemsIBA 01/2020 - 07/2002
5	Pharmaceutical PreparationsIBA 03/2020 - 12/2014
4	AntigensIBA 01/2020 - 09/2004
3	Analgesics (Analgesic Drugs)IBA 12/2021 - 01/2015
3	AntibodiesIBA 11/2019 - 11/2009
3	Immunoglobulin G (IgG)IBA 11/2016 - 11/2009
3	CytokinesIBA 01/2016 - 01/2002
2	Anesthetics (Anesthetic Agents)IBA 04/2022 - 08/2019
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 11/2021
2	Therapeutic UsesIBA 01/2022 - 11/2021
2	p38 Mitogen-Activated Protein KinasesIBA 10/2020 - 10/2017
2	Immunoglobulins (Immunoglobulin)IBA 11/2019 - 04/2016
2	Peroxidase (Myeloperoxidase)IBA 12/2018 - 01/2016
2	VaccinesIBA 12/2018 - 02/2017
2	Levobupivacaine (Chirocaine)FDA Link 01/2018 - 10/2017
2	ProstaglandinsIBA 01/2017 - 06/2002
2	Phospholipases (Phospholipase)IBA 10/2016 - 11/2004
2	Intravenous Immunoglobulins (IVIG)FDA Link 04/2016 - 01/2016
2	Cytotoxins (Cytolysins)IBA 01/2014 - 06/2010
2	Immunoglobulin Fab FragmentsIBA 08/2003 - 07/2002
1	mRNA VaccinesIBA 07/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 12/2021
1	Messenger RNA (mRNA)IBA 10/2020
1	Remifentanil (Ultiva)FDA Link 10/2020
1	preproenkephalinIBA 10/2020
1	BradykininIBA 10/2020
1	Dynorphins (Dynorphin)IBA 10/2020
1	methylnaltrexone FDA Link 10/2020
1	Bradykinin Receptor AntagonistsIBA 10/2020
1	EnzymesIBA 08/2019
1	AmmoniaIBA 08/2019
1	Urea (Carbamide)FDA LinkGeneric 08/2019
1	Arginine (L-Arginine)FDA Link 08/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	pifithrinIBA 01/2019
1	Rocuronium (Zemuron)FDA LinkGeneric 01/2019
1	InflammasomesIBA 01/2019
1	CeramidesIBA 01/2019
1	Factor X (Stuart Factor)IBA 01/2019
1	Freund's AdjuvantIBA 01/2019
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2019
1	Caspase 1 (ICE Protease)IBA 01/2019
1	Factor VIIa (Activated Factor VII)IBA 01/2019
1	CPG-oligonucleotideIBA 12/2018
1	salubrinalIBA 12/2018
1	TunicamycinIBA 12/2018
1	AcetoneIBA 12/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	CarbenoxoloneIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2022 - 08/2003
2	General Anesthesia 08/2019 - 01/2017
2	Analgesia 10/2017 - 01/2015
2	Immunotherapy 04/2016 - 09/2004
2	Tracheostomy 01/2016 - 02/2015
2	Anesthesia 01/2016 - 02/2015
1	Laparotomy 04/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Intravenous Administration 01/2022
1	Intraperitoneal Injections 12/2021
1	Transurethral Resection of Prostate (TURP) 03/2021
1	Operative Surgical Procedures 03/2021
1	Spinal Injections 01/2019
1	Tracheotomy 12/2018
1	Conservative Treatment 12/2018
1	Aftercare (After-Treatment) 12/2018
1	Ligation 12/2018